Estradiol transdermal - Bayer HealthCare Pharmaceuticals

Drug Profile

Estradiol transdermal - Bayer HealthCare Pharmaceuticals

Alternative Names: Climara; Estradiol transdermal - Berlex/3M; Femtran; Progynova TS 100; Progynova TS 50; Progynova TS Forte

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator 3M Pharmaceuticals; Bayer HealthCare Pharmaceuticals
  • Developer 3M Pharmaceuticals; Allergan; Bayer HealthCare Pharmaceuticals Inc.
  • Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Menopausal syndrome; Postmenopausal osteoporosis

Most Recent Events

  • 01 Jul 2014 Forest Laboratories has been acquired by Actavis Inc
  • 20 Aug 2013 Biomarkers information updated
  • 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare (MR 9074204)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top